Molecular Alterations and Targeted Therapy in Gastric Cancer

Dear Colleagues,

Gastric cancer is an aggressive tumor often diagnosed at advanced stages, resulting in high mortality rates. Despite recent advancements in targeted therapies and our growing understanding of the molecular landscape of gastric cancer, patient prognosis remains poor. There is an urgent need to investigate novel biomarkers that can facilitate the stratification of patients according to their prognosis and treatment options.

This Special Issue seeks contributions that focus on the identification and validation of novel biomarkers for gastric cancer. We welcome submissions that advance the field of gastric cancer research and provide insights into potential clinical applications.

Topics of interest include, but are not limited to, the following:

• Genetic and epigenetic alterations;
• Proteomic and metabolomic profiling;
• Liquid biopsy;
• Predictive markers for treatment response;
• Prognostic markers for patient stratification;
• Novel therapeutic targets and pathways;
• Novel therapeutic approaches.

We invite submissions of various types of articles, particularly original research papers and reviews. Your valuable contributions will help improve the prognosis and treatment options for patients with gastric cancer.

We look forward to your submissions.

Dr. María Jesús Fernández Aceñero
Dr. Cristina Díaz del Arco
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.